Heska Corporation HSKA
Set alert
At close · Jun 12
52-week range unavailable
- Open
- 119.96
- Prev close
- 119.99
- Mkt cap
- 1.31B
- Vol
- 330.89K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 119.99
- High
- 119.99
- Forward P/E
- 799.93
- Beta
- 1.60
- Short ratio
- 5.41
- Inst. own
- 87.54%
- Dividend
- 0.00
- Ex-div date
- Sep 25, 2012
- Earnings
- May 5, 2023
- 50-d avg
- 117.55
- 200-d avg
- 87.11
- 1y target
- 130.00
Key statistics
- Market cap
- 1.31B
- Enterprise value
- 1.29B
- Trailing P/E
- 0.00
- Forward P/E
- 799.93
- PEG ratio
- -5.71
- Price / sales
- 5.14
- Price / book
- 3.14
- EPS (TTM)
- -1.92
- Beta
- 1.60
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -7.86%
- Revenue (TTM)
- 254.89M
- Revenue growth
- -3.70%
- Free cash flow
- -5.78M
- Total cash
- 125.21M
- Total debt
- 109.92M
- Return on equity
- -4.73%
- Shares outstanding
- 10.91M
- Short % of float
- 16.75%
- 50-day average
- 117.55
- 200-day average
- 87.11
Analyst view
Consensus: buy
- Target (low)
- 120.00
- Target (mean)
- 130.00
- Target (high)
- 150.00
- Strong buy1
- Buy3
- Hold4
- Sell0
- Strong sell0
Next earnings
May 5, 2023
Expected May 5, 2023. Consensus EPS estimate -0.22.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 5, 2023 | Mar 1, 2023 | 0.32 | — | — | — |
| Feb 28, 2023 | Dec 1, 2022 | 0.38 | — | — | — |
| Nov 8, 2022 | Sep 1, 2022 | 0.45 | — | — | — |
| Aug 8, 2022 | Jun 1, 2022 | 0.37 | — | — | — |
| May 9, 2022 | Mar 1, 2022 | 0.41 | — | — | — |
| Feb 28, 2022 | Dec 1, 2021 | 0.32 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 4, 2023 | Morgan Stanley | main | — | Equal-Weight |
| Jan 6, 2023 | Morgan Stanley | down | Equal-Weight | Underweight |
| Nov 14, 2022 | Piper Sandler | main | — | Overweight |
| Nov 9, 2022 | Morgan Stanley | main | — | Equal-Weight |
| Nov 9, 2022 | Alliance Global Partners | main | — | Buy |
| Oct 17, 2022 | JP Morgan | main | — | Overweight |
About Heska Corporation
Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- heska.com
News
- Dalan Animal Health Ships First Honey Bee Vaccine to Tauzer Apiaries, Potentially Protecting 25 Million Bees.
- HESKA CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Heska Corporation - HSKA
- Heska (HSKA) Q1 Earnings and Revenues Lag Estimates
- HESKA CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Heska Corporation - HSKA
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HSKA, LSI, EXR, DFFN
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Why Heska Stock Is On Fire Today
- HSKA STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Heska Corporation Is Fair to Shareholders
- Heska Corporation (HSKA) Q4 2022 Earnings Call Transcript
- Heska (HSKA) Q4 Earnings and Revenues Surpass Estimates
Your note
Sign in to keep a note on HSKA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANTIN ROBERT L | Director | Stock Award(Grant) | May 3, 2022 | 2,189 |
| BAKER ELEANOR F | Officer | Stock Award(Grant) | Jun 12, 2023 | 0 |
| EYL STEVEN M | Officer | Stock Award(Grant) | Mar 23, 2023 | 26,904 |
| FURLONG MARK F | Director | Stock Award(Grant) | May 3, 2022 | 4,726 |
| GRASSMAN CATHERINE I | Chief Financial Officer | Stock Award(Grant) | May 31, 2023 | 14,261 |
| LARSON SHARON J. | Director | Stock Award(Grant) | May 3, 2022 | 8,608 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 17.13% | 1,869,493 | 224.32M | Mar 30, 2023 |
| Nine Ten Capital Management LLC | 8.03% | 876,008 | 105.11M | Mar 30, 2023 |
| Fred Alger Management, LLC | 7.59% | 828,868 | 99.46M | Mar 30, 2023 |
| Vanguard Group, Inc. (The) | 6.70% | 730,939 | 87.71M | Mar 30, 2023 |
| Ameriprise Financial, Inc. | 5.29% | 577,375 | 69.28M | Mar 30, 2023 |
| State Street Corporation | 3.98% | 434,464 | 52.13M | Mar 30, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Core S&P Smallcap ETF | 7.07% | 768,980 | 92.27M | Feb 27, 2023 |
| Alger Small Cap Focus Fund | 6.56% | 713,593 | 85.62M | Jan 30, 2023 |
| Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I | 3.45% | 375,208 | 45.02M | Feb 27, 2023 |
| Vanguard Total Stock Market Index Fund | 2.85% | 309,784 | 37.17M | Dec 30, 2022 |
| iShares Russell 2000 ETF | 1.94% | 211,318 | 25.36M | Feb 27, 2023 |
| iShares S&P Smallcap 600 Value ETF | 1.68% | 182,159 | 21.86M | Feb 27, 2023 |